SMSbiotech Receives New European Patent!

SMSbiotech Advancing Regenerative Therapies for Orthopedics

Embed Audio and Video files in Blog Post

Breakthrough in Angiogenesis: Small Mobile Stem Cells Drive Large Vessel Formation

From Conflict to Discovery: How Abdulkader Rahmo, PhD, is Shaping Stem Cell Research

Revolutionizing COPD Treatment: Inhaled Small Mobile Stem Cells for Lung Regeneration

Revolutionizing Regenerative Medicine: The Potential of Small Mobile Stem (SMS) Cells

A Breakthrough in COPD Regeneration: How Small Mobile Stem (SMS) Cells Transform Lung Repair

SMS Cells After RF Microneedling: New Evidence Shows Faster Recovery & Better Skin Quality

A New Era in Veterinary Regenerative Medicine: How SMS Cells Are Transforming Animal Health

SMSbiotech Announces Successful Presentation of Small Mobile Stem Cell Regenerative Mechanism in Human COPD Patients at ERS LSC 2025

SMSbiotech Featured in News for COPD Therapy

SMSbiotech Founder Featured on “HealthTech CEO Wisdom” Podcast

SMSbiotech Visits Tijuana EDC to Explore Clinical Opportunities

SMSbiotech Founder Discusses Inhaled Stem Cell Therapy for COPD in MIA Interview

European Society of Medicine Publishes Groundbreaking Article on Small Mobile Stem Cells

SMSbiotech Expands with New San Diego Bio-Manufacturing Facility

Regenerative Breakthrough in Canine Wound Healing

Early Results Demonstrate Safety and Progress in SMSbiotech’s Human COPD Study

Breakthrough Study in Horses Reinforces SMS Cell Therapy’s Platform Versatility

Dr. Rahmo Showcases SMSbiotech’s Breakthrough Cell Therapy at Biotech Global Summit.

SMSbiotech Welcomes New Advisor Steven N. Copp, MD

Milestone Achievement: First COPD Patient Dosed in Phase 1 Trial

SMSbiotech Secures New Japanese Patent

Newsweek: The New Era of Life Sciences 2025

Discover Breakthrough COPD & Regenerative Medicine Insights at RIS 2025

SMSbiotech Establishes a CRADA with the U.S. Army Medical Research Institute of Chemical Defense

9th Edition: Aging & Gerontology Event

SMSbiotech Receives Green Light for Phase I Clinical Trial in Australia, Targeting COPD

Drug Discovery Innovation Programme 2025

SMSbiotech Welcomes New Board of Advisor Member Dr. Jason P. Kirkness

A New Era of Healing: Our Latest Patent is Here!

American Thoracic Society 2024 Respiratory Innovation Summit

VIP Speaker at 7th Alcor Drug Discovery Platform

12th Annual Drug Discovery Strategic Summit

5th Annual Age-Related Disease Therapeutics Summit

Biocom Global Life Science Partnering & Investor Conference

Unveiling Hope: A Potential Breakthrough Treatment for COPD from SMSbiotech

6th Annual CGTI Leaders Summit 2023

SMSbiotech Unveils New Patented Stem-Cell Technology Designed to Treat COPD

Cell Symposia: Advances in Therapeutic Applications of Stem Cells

10th International Conference on COPD and Lung Health

Patent Application Accepted

6th Annual IPF Summit 2022

4th Annual Longevity Therapeutics Summit

Voice of America - Innovations

SMSbiotech Receives New Patent!!!

ISSCR 2022 Poster Presentation

Scientific Poster from ATS: Respiratory Innovation Summit 2022

ATS: Respiratory Innovation Summit 2022

Medicinal Chemistry Strategy Meeting - 2022

Health 2.0 - Presentation

Health 2.0 Conference 2022

Advanced Therapies Week: Phacilitate 2022

SMSbiotech Welcome Beth Thompson-Webb to Board of Directors

5th Meridian Clinical Trials Event

SMSbiotech Successfully Completes First Test of a Series of Animal Studies for COPD Treatment

SMSbiotech Announces Collaboration with Acculab Life Sciences

SMSbiotech Selected for the ACSFall2021 Sci-Mix Event

American Chemical Society Fall 2021 Presentation

Nobel Laureate, Professor Luc Montagnier, Joins the SMSbiotech Advisory Board

Small Mobile Stem Cells: Potential for Multi-Targeted Therapy of Emphysema in COPD - AASCP

Prof. Peter D. Wagner, MD joins SMSbiotech on their Advisory Board

SMSbiotech Completes Second Clinical Test for Chronic Non-Healing Wound Product

In Vitro Gene Expression Study Demonstrates Small Mobile Stem Cells Stimulate Progenitor Lung Cells

SMSbiotech Completes Clinical Test for Chronic Non-Healing Wound Product

SMSbiotech Engages Exemplar Capital for Strategic Investment Banking Services

MSC's In the Treatment of COVID-19

Interviews with Dr. Roger Schechter: Episode 5: COVID-19 Part 2 (Effects and Solutions)

Interviews with Dr. Roger Schechter EPISODE 4: COVID-19 Part 1

Meet Abdulkader Rahmo, PhD.

SMSbiotech Interviews with Dr. Roger Schechter EPISODE 3: Angiogenesis and SMS Cells

SMSbiotech Interviews with Dr. Roger Schechter EPISODE 2: Accessibility of SMS Cells

SMSbiotech Interviews with Dr. Roger Schechter EPISODE 1: Aging and Cell Therapy

Ageing Hallmarks Exhibit Organ-Specific Temporal Signatures

BioNeex Interview with SMSbiotech

ACS National Meeting & Expo

SMSbiotech Files Proposal with BARDA for a Covid-19 Treatment

SAWC Spring | WHS

Advanced Therapies Congress & Expo 2020

Joe Kiani Becomes A Major Shareholder At SMSbiotech, Inc.

SMSbiotech Introduces a New Product Website!

ANGIOstream™ In Vitro Assay Fast Track Option – Inductive Niche Module (INM)

Biotechnology Vendor Showcase™ – Southern California

Biotechnology Vendor Showcase™ Events – Southern California

Cell Symposia - Engineering Organoids and Organs

ICancer 2019: 3rd International Cancer Conference And Expo

20th Annual SoCalBio Conference

SMSbiotech Obtains Patent

Biocom Regenerative Medicine Fly-In – Washington DC

New Facility Opens In San Marcos, CA

Connector Series: SMSbiotech By Hai Truong (UCI)​

SMSbiotech Celebrates Proof of Concept Victory!

5th World Congress on Cell & Stem Cell Research, 2015

2nd International Conference and Exhibition on Cell and Gene Therapy, 2013